<!DOCTYPE html>
<html lang="en">
 <head>
  <meta charset="utf-8"/>
  <meta content="origin" name="referrer"/>
  <meta content="/images/branding/googleg/1x/googleg_standard_color_128dp.png" itemprop="image"/>
  <title>
   Genzyme subsidiary Focal, Inc. - Google Search
  </title>
  <style>
   a{color:#1a0dab;text-decoration:none;-webkit-tap-highlight-color:rgba(0,0,0,.10)}a:visited{color:#4b11a8}a:hover{text-decoration:underline}img{border:0}html{font-family:arial,sans-serif;font-size:14px;line-height:20px;-webkit-text-size-adjust:100%;color:#3c4043;word-wrap:break-word;background-color:#fff}.bz1lBb{background-color:#fff;height:93px;}.KP7LCb{background-color:#fff;padding-left:4px}.BsXmcf{position:absolute;height:1px;left:0;right:0;background-color:#dadce0}.cOl4Id{background-color:#fff}.bRsWnc{overflow:hidden}.N6RWV{height:51px}.Uv67qb{font-size:14px;line-height:20px;font-weight:bold;display:flex}.Uv67qb a,.Uv67qb span{color:#5e5e5e;height:20px;margin:4px 12px 1px;display:block;flex:none;text-align:center;}.OXXup{border-bottom:2px solid #1f1f1f}.Uv67qb .OXXup{font-weight:bold;color:#1f1f1f}a.eZt8xd:visited{color:#5e5e5e}.FElbsf{border-left:1px solid #dadce0}header article{overflow:visible}.Pg70bf{height:39px;display:-webkit-box;display:flex;display:flex;width:100%}.H0PQec{position:relative;flex:1}.Pg70bf{height:26px}.hlm7Y{height:46px;margin-top:26px;border-radius:25px;width:auto;background:#fff;box-shadow:0px 2px 6px rgba(60,64,67,0.16)}.sbc{display:flex}.Pg70bf input{}.x{width:26px;color:#70757a;line-height:40px;margin-top:3px;font:27px/38px arial, sans-serif}#qdClwb{flex:0 0 auto;padding:0;height:33px;margin-top:5px;border-top-right-radius:25px;border-bottom-right-radius:25px;width:48px;background:#fff;border:0;border-left:1px solid #dadce0;background-image:url('data:image/svg+xml,\00003csvg height="37px" width="37px" xmlns="http://www.w3.org/2000/svg">\00003cg fill="none" stroke="%234285F4">\00003cellipse cx="16.5" cy="16" rx="5.4" ry="5.4" stroke-width="2px">\00003c/ellipse>\00003cpath d="M22 21.3l4.3 4.3" stroke-linecap="round" stroke-width="2px">\00003c/path>\00003c/g>\00003c/svg>');}.sc{font-size:16px;position:absolute;top:48px;left:0;right:0;box-shadow:0 2px 5px rgba(0,0,0,.2);z-index:2;background-color:#fff}.sc>div{padding:10px 20px}.scs{background-color:#fafafa;}.noHIxc{display:block;font-size:16px;padding:0 0 0 8px;flex:1;height:35px;outline:none;border:none;width:100%;-webkit-tap-highlight-color:rgba(0,0,0,0);overflow:hidden;padding:4px 0 0 20px}.sbc input[type=text]{background:none}html{background-color:#fff;}body{padding:0;}body{margin:0 auto 0 156px;max-width:652px;min-width:652px;padding:0 8px}.cOl4Id{text-align:center;padding:32px 28px 0 24px;position:absolute;left:0;top:0}footer{text-align:center;margin-top:18px}footer a,footer a:visited,.smiUbb{color:#70757a}.xeDNfc{margin:0 13px;display:inline-block}#EOlPnc{margin-top:36px}#EOlPnc>div{margin:20px}.Srfpq{color:#70757a}
  </style>
 </head>
 <body jsmodel="hspDDf ">
  <header id="hdr">
   <div class="cOl4Id">
    <a href="/?sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQOwgC">
     <svg aria-label="Google" fill="none" height="36" stroke="#4285f4" stroke-width="18" viewbox="0 0 520 174" width="92">
      <path d="M69 70.4l61 0m-9 3.5a56 57 0 1 1-17-47" stroke-width="19px">
      </path>
      <ellipse cx="179" cy="90" rx="33" ry="34" stroke="#ea4335">
      </ellipse>
      <ellipse cx="270" cy="90" rx="33" ry="34" stroke="#fbbc04">
      </ellipse>
      <ellipse cx="358" cy="90" rx="32" ry="34" stroke-width="17px">
      </ellipse>
      <path d="M391 49l0 73l-2 0a 22 22-30 0 1-59 24">
      </path>
      <path d="M423 5l0 130" style="stroke:#34a853">
      </path>
      <path d="M509 110a32 35-3 1 1 3-29M517 76l-63 24" stroke="#ea4335" stroke-width="16px">
      </path>
     </svg>
    </a>
   </div>
   <div class="bz1lBb">
    <form class="Pg70bf hlm7Y" id="sf">
     <input name="num" type="hidden" value="100"/>
     <input name="lr" type="hidden" value="lang_en"/>
     <input name="sca_esv" type="hidden" value="838ca97d1d112653"/>
     <input name="sca_upv" type="hidden" value="1"/>
     <input name="hl" type="hidden" value="en"/>
     <input name="gbv" type="hidden" value="1"/>
     <input name="gl" type="hidden" value="us"/>
     <input name="tbs" type="hidden" value="lr:lang_1en"/>
     <div class="H0PQec">
      <div class="sbc esbc">
       <input autocapitalize="none" autocomplete="off" class="noHIxc" name="q" spellcheck="false" type="text" value="Genzyme subsidiary Focal, Inc."/>
       <input name="oq" type="hidden"/>
       <input name="aqs" type="hidden"/>
       <div class="sc">
       </div>
      </div>
     </div>
     <button id="qdClwb" type="submit">
     </button>
    </form>
   </div>
  </header>
  <div id="main">
   <div>
    <div class="KP7LCb">
     <div class="bRsWnc">
      <div class="N6RWV">
       <div class="Pg70bf Uv67qb">
        <span class="OXXup">
         All
        </span>
        <a class="eZt8xd" href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=nws&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQ_AUIBigB">
         News
        </a>
        <a class="eZt8xd" href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=isch&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQ_AUIBygC">
         Images
        </a>
        <a class="eZt8xd" href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=bks&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQ_AUICCgD">
         Books
        </a>
        <a href="/url?q=https://maps.google.com/maps%3Fhl%3Den%26q%3DGenzyme%2Bsubsidiary%2BFocal,%2BInc.%26iflsig%3DAL9hbdgAAAAAZpa0f0F8S4afo_Lcs2_eeIcoXheM8Jht%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26um%3D1%26ie%3DUTF-8%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQiaAMCAkoBA&amp;usg=AOvVaw3BtIZTDqFOqxb_dj3QUYtV">
         Maps
        </a>
        <a href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=vid&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQ_AUICigF">
         Videos
        </a>
        <a href="/url?q=/search%3Fq%3DGenzyme%2Bsubsidiary%2BFocal,%2BInc.%26num%3D100%26lr%3Dlang_en%26sca_esv%3D838ca97d1d112653%26sca_upv%3D1%26hl%3Den%26gbv%3D1%26gl%3Dus%26tbs%3Dlr:lang_1en%26tbm%3Dshop%26source%3Dlnms%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQiaAMCAsoBg&amp;usg=AOvVaw05UMgurCW8nO4hu5XWe5Dr">
         Shopping
        </a>
        <div class="FElbsf">
         <a href="/advanced_search" id="st-toggle" role="button" style="white-space:nowrap">
          Search tools
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
    <div class="Pg70bf wEsjbd Gx5Zad xpd EtOod pkphOe" id="st-card">
     <style>
      .wEsjbd{height:44px;white-space:nowrap}.coPU8c{height:60px;-webkit-overflow-scrolling:touch;overflow-x:auto;overflow-y:hidden}.Xj2aue{height:44px;overflow:hidden}.RnNGze{margin:11px 16px}.wEsjbd div,.wEsjbd a,.wEsjbd li{outline-width:0;outline:none}
     </style>
     <div class="Xj2aue">
      <div class="coPU8c">
       <div class="RnNGze">
        <style>
         .PA9J5{display:inline-block}.RXaOfd,.tbcPJb{display:inline-block;height:22px;position:relative;padding-top:0;padding-bottom:0;padding-right:16px;padding-left:0;line-height:22px;cursor:pointer;text-transform:uppercase;font-size:12px;color:#70757a}.sa1toc{background:#fff;display:none;position:absolute;border:1px solid #dadce0;box-shadow:0 2px 4px rgba(0,0,0,.3);margin:0;white-space:nowrap;z-index:103;line-height:17px;padding-top:5px;padding-bottom:5px;padding-left:0}.PA9J5:hover .sa1toc{display:block}.mGSy8d a:active,.RXaOfd:active{color:#4285f4}
        </style>
        <div class="PA9J5">
         <div class="RXaOfd vQYuGf" role="button" tabindex="0">
          <style>
           .TWMOUc{display:inline-block;padding-right:14px;white-space:nowrap}.vQYuGf{font-weight:bold}.OmTIzf{border-color:#909090 transparent;border-style:solid;border-width:4px 4px 0 4px;width:0;height:0;margin-left:-10px;top:50%;margin-top:-2px;position:absolute}.RXaOfd:active .OmTIzf{border-color:#4285f4 transparent}
          </style>
          <div class="TWMOUc">
           Search English pages
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <style>
           .ozatM{font-size:12px;text-transform:uppercase}.ozatM .yNFsl,.ozatM li{list-style-type:none;list-style-position:outside;list-style-image:none}.yNFsl.SkUj4c,.yNFsl a{color:#70757a;text-decoration:none;padding:6px 44px 6px 14px;line-height:17px;display:block}.SkUj4c{background-image:url(//ssl.gstatic.com/ui/v1/menu/checkmark2.png);background-position:right center;background-repeat:no-repeat}.SkUj4c:active{background-color:#f8f9fa}
          </style>
          <li class="yNFsl">
           <style>
            .tbcPJb a{color:#70757a;text-decoration:none}
           </style>
           <a href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbas=0&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQpwUIDA">
            Any language
           </a>
          </li>
          <li class="yNFsl SkUj4c">
           Search English pages
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           Any time
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           Any time
          </li>
          <li class="yNFsl">
           <a href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:h&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQpwUIDw">
            Past hour
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:d&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQpwUIEA">
            Past 24 hours
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:w&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQpwUIEQ">
            Past week
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:m&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQpwUIEg">
            Past month
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:y&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQpwUIEw">
            Past year
           </a>
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           All results
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           All results
          </li>
          <li class="yNFsl">
           <a href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=li:1&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQpwUIFQ">
            Verbatim
           </a>
          </li>
         </ul>
        </div>
        <div class="tbcPJb" role="button" tabindex="0">
         <a href="https://www.google.com/search?hl=en&amp;source=hp&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;btnG=Google+Search&amp;iflsig=AL9hbdgAAAAAZpa0f0F8S4afo_Lcs2_eeIcoXheM8Jht&amp;gbv=1&amp;gl=us&amp;num=100">
          Clear
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div class="BsXmcf">
   </div>
   <style>
    .Gx5Zad{margin-bottom:30px;margin:0px 0px 8px;}.pkphOe{font-size:14px;line-height:22px;}.EtOod>*:first-child{border-top-left-radius:8px;border-top-right-radius:8px}.EtOod>*:last-child{border-bottom-left-radius:8px;border-bottom-right-radius:8px}.EtOod.avPKgf>*:last-child{border-bottom-left-radius:4px}.EtOod>.qxDOhb>*:first-child{border-top-left-radius:8px;border-top-right-radius:8px}.EtOod>.qxDOhb>*:last-child{border-bottom-left-radius:8px;border-bottom-right-radius:8px}.fP1Qef{background:transparent !important;box-shadow:none !important;border:none !important}.rl7ilb{display:block;clear:both}.egMi0{margin-bottom:-23px}.kCrYT{padding:16px 14px 12px}a.fdYsqf{color:#4b11a8}.sCuL3{position:absolute;width:100%;top:0;left:0;padding-top:1px;margin-bottom:-1px}.j039Wc{padding-top:28px;margin-bottom:-1px}.DnJfK{position:relative}.l97dzf{font-weight:400}.zBAuLc{line-height:normal;margin:0;padding:0}.BNeawe{white-space:pre-line;word-wrap:break-word}.vvjwJb{color:#1a0dab;font-size:20px;line-height:26px}a:visited .vvjwJb,.vvjwJb a:visited{color:#4b11a8}.vvjwJb.HrGdeb{color:#fff}a:visited .vvjwJb.HrGdeb,.vvjwJb.HrGdeb a:visited{color:rgba(255,255,255,.70)}.UwRFLe{display:-webkit-box;-webkit-box-orient:vertical;overflow:hidden}.UPmit{font-size:14px;line-height:22px}.UPmit.HrGdeb{color:rgba(255,255,255,.70)}.UPmit.AP7Wnd{color:#202124}.lRVwie{text-overflow:ellipsis;white-space:nowrap;overflow:hidden}.Ap5OSd{padding-bottom:12px}.s3v9rd{font-size:14px;line-height:22px}.s3v9rd.HrGdeb{color:#fff}.s3v9rd.AP7Wnd{color:#202124}.mSx1Ee{padding-left:48px;margin:0}.v9i61e{padding-bottom:8px}.XLloXe{color:#1a0dab;font-size:14px;line-height:20px}a:visited .XLloXe,.XLloXe a:visited{color:#4b11a8}.XLloXe.HrGdeb{color:#fff}a:visited .XLloXe.HrGdeb,.XLloXe.HrGdeb a:visited{color:rgba(255,255,255,.70)}.U8ml0d{text-decoration:line-through}.K8tyEc{padding-bottom:12px}.mEUgP{font-size:20px;font-weight:bold;line-height:26px;color:#1f1f1f;height:14px;padding:16px 14px 0px 14px;margin:0}.FCUp0c{font-weight:bold}.nRlVm .FCUp0c{background-color:#d3e3fd;color:#040c28}.C7GS5b{margin-left:12px;display:table-cell;vertical-align:middle}.rkGIWe{padding:14px}.rxk4ae{padding-top:6px;padding-bottom:6px}.yStFkb .xpd{box-shadow:none;border-radius:16px;background-color:#f7f8f9;}.oTWEpb{padding-top:16px}.n1Qedd{overflow:hidden;text-align:center}.KMAGC{margin:0 auto;display:block}.ho0sdc{margin:0 -50%;display:inline-block}.PqksIc{font-size:16px;line-height:20px}.x54gtf{height:1px;background-color:#dadce0;margin:0 14px}.Q0HXG{height:1px;background-color:#dadce0;}.Xb5VRe{color:#1a0dab}a:visited .Xb5VRe{color:#4b11a8}.Xb5VRe.tr0dw{color:#fff}a:visited .Xb5VRe.tr0dw{color:rgba(255,255,255,.70)}.P1NWSe{display:table;width:100%;padding-top:16px;padding-bottom:16px;margin-bottom:-12px}.wOMIed{display:table-cell;vertical-align:top}.nkPlDb{vertical-align:middle}.JhFlyf{color:#3c4043;font-size:14px;text-align:center}.VQFmSd{display:block;white-space:pre-line;word-wrap:break-word}.JhFlyf.VQFmSd{line-height:22px}.f4J0H{padding:18px}.r0bn4c.tr0dw{color:rgba(255,255,255,.70)}.r0bn4c.rQMQod{color:#70757a}.tP9Zud{display:inline-block;}.QzarWc{color:#3c4043}.oqSTJd{color:#70757a}.Hk2yDb,.Hk2yDb span{width:65px;height:15px;display:inline-block;background:repeat-x 0 0;background-size:13px 15px;font-size:0;line-height:0}.Hk2yDb.KsR1A{background-image:url("data:image/svg+xml,\00003csvg width='13px' height='15px' xmlns='http://www.w3.org/2000/svg'>\00003cpath fill='%23d1d1d1' d='m0,7.6l4.7,0,1.5-4.5,1.5,4.5,4.7,0-3.8,2.8,1.5,4.5-3.8-2.8-3.8,2.8,1.5-4.5'/>\00003c/svg>")}.Hk2yDb.KsR1A span{background-image:url("data:image/svg+xml,\00003csvg width='13px' height='15px' xmlns='http://www.w3.org/2000/svg'>\00003cpath fill='%23fabb05' d='m0,7.6l4.7,0,1.5-4.5,1.5,4.5,4.7,0-3.8,2.8,1.5,4.5-3.8-2.8-3.8,2.8,1.5-4.5'/>\00003c/svg>")}.cAuxJf{font-size:20px;font-weight:bold;line-height:26px;color:#1f1f1f;margin:0}.tAd8D{font-size:14px;line-height:20px}.tAd8D.HrGdeb{color:rgba(255,255,255,.70)}.tAd8D.AP7Wnd{color:#70757a}.Xdlr0d{overflow-x:auto;-webkit-overflow-scrolling:touch;margin:0 -8px;padding:2px 0 16px 22px;margin-top:-2px;transform:translate3d(0,0,0)}.idg8be{display:table;border-collapse:separate;border-spacing:8px 0;margin:0 -8px;padding-right:14px}.BVG0Nb{display:table-cell;vertical-align:top;overflow:hidden;}.pijXPc{overflow:hidden;border-radius:16px;background-color:#f7f8f9;font-size:18px}.OxTOff{overflow:hidden;border-radius:8px;background-color:#f7f8f9}.WddBJd{display:block;margin:0 auto;border-radius:8px}.RJI4s{vertical-align:middle}.mHhylf{display:table-cell;vertical-align:middle}.WZ5GJf{align-items:center;padding:0 20px;min-width:112px}.qN9Ked,.DXk5Me{margin:0 auto;color:#001d35}.DXk5Me{cursor:pointer;margin-bottom:12px}.Dk7jOe{display:block;margin:0 auto}.Qi9Fd{border:0;border-radius:999px;display:block;height:56px;justify-content:center;width:56px;z-index:0;background:#f7f8f9;}.Qi9Fd:focus{outline:none}.Qi9Fd .hWHuJ{display:block;margin:0 auto}.ji5jpf{text-align:center}.rLshyf,.BmP5tf{padding-top:16px;padding-bottom:12px}.YOx3Ab{padding-left:14px;}.w1C3Le,.BmP5tf,.G5NbBd,.CS4w5b{padding-left:14px;padding-right:14px;}.G5NbBd{padding-bottom:12px}.CS4w5b{padding-top:12px}.nMymef{display:flex}.G5eFlf{flex:1;display:block}.nMymef span{text-align:center}.EYqSq{margin:6px 4px 9px 0;border-radius:100%;display:inline-block;height:10px;vertical-align:middle;width:10px}.dfB0uf{color:#3c4043;font-weight:bold}.IffyKc{word-wrap:break-word}
   </style>
   <div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAQQAg" href="/url?q=https://en.wikipedia.org/wiki/Genzyme&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAQQAg&amp;usg=AOvVaw3uqOnOoGbpv7kpLJvs7EgY">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genzyme - Wikipedia
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          en.wikipedia.org › wiki › Genzyme
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its ...
          </div>
         </div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="BNeawe">
            <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ0gJ6BAgEEAU" href="/url?q=https://en.wikipedia.org/wiki/Genzyme%23History&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ0gJ6BAgEEAU&amp;usg=AOvVaw1icOmitAgiwQUtxG0Kx3qs">
             <span class="XLloXe AP7Wnd">
              History
             </span>
            </a>
           </span>
           ·
           <span class="BNeawe">
            <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ0gJ6BAgEEAY" href="/url?q=https://en.wikipedia.org/wiki/Genzyme%23Operations&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ0gJ6BAgEEAY&amp;usg=AOvVaw2cioNUP-p5p9Nwu8uNxKsA">
             <span class="XLloXe AP7Wnd">
              Operations
             </span>
            </a>
           </span>
           ·
           <span class="BNeawe">
            <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ0gJ6BAgEEAc" href="/url?q=https://en.wikipedia.org/wiki/Genzyme%23Contamination_incidents&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ0gJ6BAgEEAc&amp;usg=AOvVaw35FcMOYrJntEiAsjbjw630">
             <span class="XLloXe AP7Wnd">
              Contamination incidents
             </span>
            </a>
           </span>
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Focal,
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ5t4CegQIBBAJ" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Genzyme+subsidiary+%22Focal,%22+Inc.&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ5t4CegQIBBAJ">
             <span class="XLloXe AP7Wnd">
              Focal,
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad xpd EtOod pkphOe">
     <div class="K8tyEc">
      <div class="mEUgP">
       <span>
        <div class="BNeawe">
         <span class="FCUp0c rQMQod">
          People also ask
         </span>
        </div>
       </span>
      </div>
     </div>
     <div>
      <span class="C7GS5b rkGIWe rxk4ae">
       <div class="BNeawe s3v9rd AP7Wnd">
        What company owns Genzyme?
       </div>
      </span>
      <div class="kCrYT" style="padding-bottom:12px;padding-top:0px">
       <div class="yStFkb">
        <div class="Gx5Zad xpd EtOod pkphOe">
         <div class="kCrYT">
          <div class="PqksIc nRlVm">
           <div class="BNeawe">
            <div class="Ap5OSd">
             <div class="BNeawe">
              <span class="FCUp0c rQMQod">
               Sanofi
              </span>
             </div>
            </div>
            <div>
             <div class="BNeawe">
              Genzyme was an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) has been a fully owned subsidiary of
              <span class="FCUp0c rQMQod">
               Sanofi
              </span>
              .
             </div>
            </div>
           </div>
          </div>
         </div>
         <div class="x54gtf">
         </div>
         <div class="kCrYT">
          <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAYQBg" href="/url?q=https://en.wikipedia.org/wiki/Genzyme&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAYQBg&amp;usg=AOvVaw181V0ZxNIy6gMGKkC_a2RU">
           <span>
            <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             <span class="rQMQod Xb5VRe">
              Genzyme - Wikipedia
             </span>
            </div>
           </span>
           <span>
            <div class="BNeawe UPmit AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             en.wikipedia.org › wiki › Genzyme
            </div>
           </span>
          </a>
         </div>
        </div>
       </div>
       <div>
        <div class="P1NWSe">
         <div class="wOMIed nkPlDb">
          <span class="JhFlyf VQFmSd">
           <a class="f4J0H" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQzmd6BAgGEAc" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=b6aWZozZGZ3KkPIP_-mcyAI&amp;q=What+company+owns+Genzyme?&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQzmd6BAgGEAc">
            More results
           </a>
          </span>
         </div>
        </div>
       </div>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <span class="C7GS5b rkGIWe rxk4ae">
       <div class="BNeawe s3v9rd AP7Wnd">
        How much did Sanofi pay for Genzyme?
       </div>
      </span>
      <div class="kCrYT" style="padding-bottom:12px;padding-top:0px">
       <div class="yStFkb">
        <div class="Gx5Zad xpd EtOod pkphOe">
         <div class="kCrYT">
          <div class="PqksIc nRlVm">
           <div class="BNeawe">
            <div>
             <div class="BNeawe">
              PARIS (Reuters) - French drugmaker Sanofi-Aventis SA clinched its long-sought deal for Genzyme Corp with a sweetened
              <span class="FCUp0c rQMQod">
               $20.1 billion
              </span>
              cash offer, plus payments tied to the success of the U.S. biotech group's drugs.
             </div>
            </div>
           </div>
          </div>
         </div>
         <div class="x54gtf">
         </div>
         <div class="kCrYT">
          <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAYQDQ" href="/url?q=https://www.reuters.com/article/world/sanofi-to-buy-genzyme-for-more-than-20-billion-idUSTRE71E4XI/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAYQDQ&amp;usg=AOvVaw3NWu6Q3pqIAYMy6OQ8iK2-">
           <span>
            <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             <span class="rQMQod Xb5VRe">
              Sanofi to buy Genzyme for more than $20 billion - Reuters
             </span>
            </div>
           </span>
           <span>
            <div class="BNeawe UPmit AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             www.reuters.com › article › world › sanofi-to-buy-genzyme-for-more-than...
            </div>
           </span>
          </a>
         </div>
        </div>
       </div>
       <div>
        <div class="P1NWSe">
         <div class="wOMIed nkPlDb">
          <span class="JhFlyf VQFmSd">
           <a class="f4J0H" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQzmd6BAgGEA4" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=b6aWZozZGZ3KkPIP_-mcyAI&amp;q=How+much+did+Sanofi+pay+for+Genzyme?&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQzmd6BAgGEA4">
            More results
           </a>
          </span>
         </div>
        </div>
       </div>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <span class="C7GS5b rkGIWe rxk4ae">
       <div class="BNeawe s3v9rd AP7Wnd">
        Where is Sanofi Genzyme?
       </div>
      </span>
      <div class="kCrYT" style="padding-bottom:12px;padding-top:0px">
       <div class="yStFkb">
        <div class="Gx5Zad xpd EtOod pkphOe">
         <div class="kCrYT">
          <div class="PqksIc nRlVm">
           <div class="BNeawe">
            <div>
             <div class="BNeawe">
              The Company¹s headquarters are located in
              <span class="FCUp0c rQMQod">
               Cambridge, Massachusetts, USA
              </span>
              .
             </div>
            </div>
           </div>
          </div>
         </div>
         <div class="x54gtf">
         </div>
         <div class="kCrYT">
          <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAYQFA" href="/url?q=https://www.massbio.org/members/sanofi-genzyme/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAYQFA&amp;usg=AOvVaw2YnqEXg4MBCR3gNWmlwNqK">
           <span>
            <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             <span class="rQMQod Xb5VRe">
              Sanofi Genzyme - MassBio
             </span>
            </div>
           </span>
           <span>
            <div class="BNeawe UPmit AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             www.massbio.org › members › sanofi-genzyme
            </div>
           </span>
          </a>
         </div>
        </div>
       </div>
       <div>
        <div class="P1NWSe">
         <div class="wOMIed nkPlDb">
          <span class="JhFlyf VQFmSd">
           <a class="f4J0H" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQzmd6BAgGEBU" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=b6aWZozZGZ3KkPIP_-mcyAI&amp;q=Where+is+Sanofi+Genzyme?&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQzmd6BAgGEBU">
            More results
           </a>
          </span>
         </div>
        </div>
       </div>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <span class="C7GS5b rkGIWe rxk4ae">
       <div class="BNeawe s3v9rd AP7Wnd">
        What is genzyme genetics?
       </div>
      </span>
      <div class="kCrYT" style="padding-bottom:12px;padding-top:0px">
       <div class="yStFkb">
        <div class="Gx5Zad xpd EtOod pkphOe">
         <div class="kCrYT">
          <div class="PqksIc nRlVm">
           <div class="BNeawe">
            <div>
             <div class="BNeawe">
              Genzyme Genetics is
              <span class="FCUp0c rQMQod">
               a leading worldwide provider of reproductive and oncology diagnostic testing, as well as genetic counselling services
              </span>
              . As a business unit of Genzyme Corporation, Genzyme Genetics employs over 1,500 people and has eight laboratories located across the United States and operations in Europe and Japan.
             </div>
            </div>
           </div>
          </div>
         </div>
         <div class="x54gtf">
         </div>
         <div class="kCrYT">
          <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAYQGw" href="/url?q=https://lanterman.ca.networkofcare.org/dd/services/agency.aspx%3Fpid%3Dgenzymegenetics_581_6_0&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAYQGw&amp;usg=AOvVaw1AFJ4gZ0p_Qni_QgTHMfbX">
           <span>
            <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             <span class="rQMQod Xb5VRe">
              GENZYME GENETICS - Los Angeles - Frank D. Lanterman Regional ...
             </span>
            </div>
           </span>
           <span>
            <div class="BNeawe UPmit AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             lanterman.ca.networkofcare.org › services › agency › pid=genzymegenetic...
            </div>
           </span>
          </a>
         </div>
        </div>
       </div>
       <div>
        <div class="P1NWSe">
         <div class="wOMIed nkPlDb">
          <span class="JhFlyf VQFmSd">
           <a class="f4J0H" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQzmd6BAgGEBw" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=b6aWZozZGZ3KkPIP_-mcyAI&amp;q=What+is+genzyme+genetics?&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQzmd6BAgGEBw">
            More results
           </a>
          </span>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECGMQAg" href="/url?q=http://www.sec.gov/Archives/edgar/data/732485/000119312511096383/ds8pos.htm&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECGMQAg&amp;usg=AOvVaw1etqqbSyctC7l6C-lmqBzu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Post-Effective Amendment No. 1 to Form S-8 Registration Statement ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › Archives › edgar › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... wholly owned subsidiary of Genzyme with and into Focal, Inc. originally granted under the Focal, Inc. 1992 Incentive Stock Plan, 1999 Stock Incentive Plan ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCUQAg" href="/url?q=https://www.sec.gov/Archives/edgar/data/732485/000091205702012898/a2073695z10-k.htm&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCUQAg&amp;usg=AOvVaw2bekcnBNn2nmnDsXwgdtHA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           genzyme corporation - SEC.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › Archives › edgar › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           FocalSeal®-L surgical sealant was developed by Focal, Inc., which we acquired in July 2001. ... The primary focus of Genzyme Molecular Oncology's internal ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECGIQAg" href="/url?q=https://pitchbook.com/profiles/company/25274-35&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECGIQAg&amp;usg=AOvVaw35NthOktynIpuSfFHXLK0p">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Sanofi Genzyme Company Profile 2024 - PitchBook
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          pitchbook.com › profiles › company
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           The company focuses on rare genetic disease disorders, renal diseases, orthopedics, cancers, transplant and immune diseases, and diagnostic and predictive ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            Inc.
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ5t4CegQIYhAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Genzyme+subsidiary+Focal,+%22Inc.%22&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ5t4CegQIYhAF">
             <span class="XLloXe AP7Wnd">
              Inc.
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFoQAg" href="/url?q=https://discovery.patsnap.com/company/genzyme-biosurgery&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFoQAg&amp;usg=AOvVaw0xF0WI7u_usPhzIKfxTxEp">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genzyme Biosurgery Corp. - Discovery PatSnap
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          discovery.patsnap.com › company › genzyme-biosurgery
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Subsidiary Lists. Subsidiaries with patent applications for Genzyme Biosurgery Corp. Company. Topics. Patents. Discovery | Patsnap. Focal, Inc. Massachusetts ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECF8QAg" href="/url?q=https://www.bioworld.com/articles/389090-other-news-to-note&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECF8QAg&amp;usg=AOvVaw1U6pziZWmawLaHfXFR7Jml">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Other News To Note + | Bioworld | BioWorld
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bioworld.com › articles › 389090-other-news-to-note
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Genzyme Corp., of Cambridge, Mass., and Focal Inc. ... Genzyme, which owns 22 percent of Focal, plans to acquire ... wholly owned subsidiary, Intellivax ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEYQAg" href="/url?q=https://investors.ocutx.com/node/8276/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEYQAg&amp;usg=AOvVaw0EVNkEjKVDz9gLUf_EpRMh">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Ocular Therapeutix, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.ocutx.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Focal, Inc., a biopharmaceutical company subsequently acquired by Genzyme Corporation. ... Inc., as Chief Financial Officer of Cephalon, Inc. and as Chief ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECGAQAg" href="/url?q=https://scrip.citeline.com/deals/199520093&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECGAQAg&amp;usg=AOvVaw3FexovN5-ysWEFH_Sz9LSC">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Focal devising delivery system for Roche restenosis drug - Scrip
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          scrip.citeline.com › deals
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Focal signed a multi-year research agreement with Roche and its US subsidiary Hoffmann-La Roche to develop a local delivery system for a drug to reduce ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECF0QAg" href="/url?q=https://www.massdevice.com/semprus-steals-weaver-boston-scientific/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECF0QAg&amp;usg=AOvVaw0VMnIFl0sKGUFzPlf7h0F7">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Semprus steals Weaver from Boston Scientific - MassDevice
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.massdevice.com › semprus-steals-weaver-boston-scientific
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Genzyme Biosurgery Inc. (NSDQ:GENZ) and Focal Inc., a synthetic surgical sealant manufacturer that Genzyme acquired, according to Semprus. "Doug's expertise ...
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Missing:
           <span class="U8ml0d rQMQod">
            subsidiary
           </span>
           | Show results with:
           <span class="BNeawe">
            <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ5t4CegQIXRAF" href="/search?num=100&amp;lr=lang_en&amp;sa=G&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;q=Genzyme+%22subsidiary%22+Focal,+Inc.&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ5t4CegQIXRAF">
             <span class="XLloXe AP7Wnd">
              subsidiary
             </span>
            </a>
           </span>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFsQAg" href="/url?q=https://www.bioworld.com/content/biotech-mergers-and-acquisitions-2001&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFsQAg&amp;usg=AOvVaw3v233vr8HrTttrVac9P0cd">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Biopharma M&amp;As in 2001 - BioWorld
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bioworld.com › content › biotech-mergers-and-acquisitions-2001
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Focal Inc. (FOCL), Genzyme Corp. (GENZ), $15.90, 7/2/01. Gemini Genomics plc (UK; GMNI), Sequenom Inc. (SQNM), $238.00, 9/20/01. Gendaq Ltd. (UK), Sangamo ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFwQAg" href="/url?q=https://papers.ssrn.com/sol3/Delivery.cfm/UVA-F-1660.pdf%3Fabstractid%3D2974482%26mirid%3D1&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFwQAg&amp;usg=AOvVaw0x3mfNAY0vpH7OCzG9G2Rn">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Genzyme and Relational Investors: Science and Business Collide?
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          papers.ssrn.com › sol3 › Delivery.cfm › UVA-F-1660
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           purchased a small company, Whatman Biochemicals Ltd., which was absorbed into Genzyme. In. 1983 (the same year that the Orphan Drug Act was passed), they ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFkQAg" href="/url?q=https://synapse.patsnap.com/organization/bbc5fe68369d38a0223445bb4a014033&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFkQAg&amp;usg=AOvVaw2Mlpas085Dw0fYlql_7-tK">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genzyme Corp. - Drug pipelines, Patents, Clinical trials - Synapse
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          synapse.patsnap.com › organization
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Sanofi Genzyme is a global business unit of Sanofi that specializes in rare diseases, multiple sclerosis, immunology, and oncology.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFcQAg" href="/url?q=https://ir.voyagertherapeutics.com/node/8451/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFcQAg&amp;usg=AOvVaw1qMzRxxoWb3AMuvuoo5Onk">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Voyager Therapeutics Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.voyagertherapeutics.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Genzyme Corporation, a biopharmaceutical company, from 2006 to 2011. He began his career in the industry as a consultant at Kendall Strategies, the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFYQAg" href="/url?q=https://investors.vcel.com/static-files/0319757e-09b1-44b8-b852-32bf1a60fa3f&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFYQAg&amp;usg=AOvVaw0aiRV4Djy0nQ0ZIgWXSmOk">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Aastrom Biosciences, Inc. - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.vcel.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... focal chondral defects on the distal femur). MACI ® (Matrix-induced ... Genzyme Therapeutics, Ltd. —, —, 81. Genzyme Corporation, 28, 17. —. All other ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFMQAg" href="/url?q=http://getfilings.com/o0000912057-01-506403.html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFMQAg&amp;usg=AOvVaw0MurbDNZlduSBxVp7V5SkM">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GENZYME CORP - 10-K Annual Report - 12/31/2000 - Get Filings
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          getfilings.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           FocalSeal-Registered Trademark--L is a registered trademark of Focal, Inc. ... 2000, among Genzyme, Titan Acquisition Corp. and GelTex as amended. Filed as ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFgQAg" href="/url?q=https://synapse-patsnap-com.libproxy1.nus.edu.sg/organization/bbc5fe68369d38a0223445bb4a014033&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFgQAg&amp;usg=AOvVaw2KYUyfG0ySI453W0voMEij">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genzyme Corp. - Drug pipelines, Patents, Clinical trials - Synapse
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          synapse-patsnap-com.libproxy1.nus.edu.sg › organization
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Sanofi Genzyme is a global business unit of Sanofi that specializes in rare diseases, multiple sclerosis, immunology, and oncology.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFQQAg" href="/url?q=https://bcilifescienceadvisors.com/en/transactions/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFQQAg&amp;usg=AOvVaw2Ng3bKKjMPgR107tREfFQf">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Select Transactions - BCI LifeSciences LLC
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          bcilifescienceadvisors.com › transactions
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Noven Pharmaceuticals, Inc. Private, JDS Pharmaceuticals, Private, Advisory: For Buyer, 125. Focal, Inc, Private, Genzyme BioSurgery, now NYSE:SNY ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFUQAg" href="/url?q=http://www.spaceoar.com/assets/XconomyBoston09-04-08.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFUQAg&amp;usg=AOvVaw3JvKWpIjn9867OOMc9rpiG">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Xconomy Boston - SpaceOAR Hydrogel
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.spaceoar.com › assets › XconomyBoston09-04-08
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Sep 4, 2008
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           I-Therapeutix, Inc. Receives. $6,000,000 Series B ... By the way, Genzyme (NASDAQ:GENZ) acquired Focal in 2001 to become part of its.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFIQAg" href="/url?q=https://www.sanofi.com/assets/dotcom/content-app/publications/annual-report-on-form-20-f/2013-01-01-form-20-f-2013-en.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFIQAg&amp;usg=AOvVaw1FGEInDo4XremcXDwckjji">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] FORM 20-F 2013 | Sanofi
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sanofi.com › publications › 2013-01-01-form-20-f-2013-en
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2013
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Corporation; Humaneered a trademark of KaloBios Pharmaceuticals; iPhone and iPod Touch trademarks of Apple Inc.; Lactacyd a trademark of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFEQAg" href="/url?q=https://investors.vcel.com/static-files/88bcc1f1-975f-4034-96b0-3ba9c0b3e858&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFEQAg&amp;usg=AOvVaw0hagQ_lDWALdpT62eKEmNa">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] UNITED STATES SECURITIES AND ... - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.vcel.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Genzyme Corporation, a Massachusetts corporation ("Genzyme") when Genzyme was acquired by Sanofi in April 2011. The CTRM business has been a pioneer in the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECE4QAg" href="/url?q=http://getfilings.com/o0000912057-00-014941.html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECE4QAg&amp;usg=AOvVaw1H5lF1SocSs1ts7tw6OleG">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GENZYME CORP - 10-K Annual Report - 12/31/1999 - Get Filings
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          getfilings.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Focal, Inc. ... Transgenics Corporation. MR. VAN HEEK joined us in September 1991 as General Manager of our wholly-owned subsidiary, Genzyme, B.V., and became a ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECE8QAg" href="/url?q=http://www.actokine.com/studentvisionorg/12thSymposiumSpeakers.html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECE8QAg&amp;usg=AOvVaw0CbdRdk6F7jvgGMpgoa-zW">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Student Vision - Actokine Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.actokine.com › studentvisionorg
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Focal, Inc. (1993-2000), and Vice President, Biomaterials Research at Genzyme Corporation (2000-present). His career focus has been polymeric biomaterials ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFAQAg" href="/url?q=https://www.encyclopedia.com/books/politics-and-business-magazines/millennium-pharmaceuticals-inc&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECFAQAg&amp;usg=AOvVaw0JHB7jMlOIRhSBCVPs4rVL">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Millennium Pharmaceuticals, Inc. | Encyclopedia.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.encyclopedia.com › books › politics-and-business-magazines › mille...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           in 1990, and Focal, Inc. in 1991. While starting these companies and ... Amgen, Inc.; Genentech Inc.; Genzyme Corporation. Further Reading. Aoki ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEoQAg" href="/url?q=https://biopharmguy.com/links/company-by-name-defunct.php&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEoQAg&amp;usg=AOvVaw2Mrd7ZzWZeAqP9nbv2TSwp">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           List of bankrupt, sold, merged, or otherwise defunct biotech, pharma ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          biopharmguy.com › links › company-by-name-defunct
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Acquired by Genzyme, Dec 2004, $1B in stock. Add'l Locations Illumicure ... Acquired by INC Research 2011. Add'l Locations Kenta Biotech, Assets acquired ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEsQAg" href="/url?q=https://www.sanofi.com/assets/dotcom/content-app/publications/annual-report-on-form-20-f/2014-01-01-form-20-f-2014-en.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEsQAg&amp;usg=AOvVaw2lKM0zlgttodoP0yGRHlLV">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] FORM 20-F 2014 | Sanofi
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sanofi.com › publications › 2014-01-01-form-20-f-2014-en
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 31, 2013
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Corporation; Aldurazyme a trademark of the Joint Venture Biomarin/Genzyme LLC; Avilomics a trademark of Avila Therapeutics Inc.; Cialis OTC ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECE0QAg" href="/url?q=https://www.sciencedirect.com/science/article/am/pii/S0048733321000214&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECE0QAg&amp;usg=AOvVaw39Mt5YbBEfmkqUVQvpvb1X">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Matching patents to compustat firms, 1980–2015 - ScienceDirect.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sciencedirect.com › science › article › pii
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 7, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           dalone company, because it has been spun-off by GENZYME CORP. A ... most recent name of the focal corporation. For example, when Google ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEwQAg" href="/url?q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340106/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEwQAg&amp;usg=AOvVaw3qdSz60iC3NFG4d8Z0zGOO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Imiglucerase in the treatment of Gaucher disease: a history and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ncbi.nlm.nih.gov › pmc › articles › PMC3340106
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 18, 2012
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The fortunes of the Genzyme Corporation, latterly acquired by global giant Sanofi SA, were founded on the evolution of a blockbuster therapy for ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEkQAg" href="/url?q=https://www.globenewswire.com/en/news-release/2023/06/07/2683844/0/en/Enhancing-Care-Expansion-of-Alpers-Disease-Treatment-Market-Size-On-its-Path-to-US-1-90-Billion-by-2030-at-a-4-57-of-CAGR.html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEkQAg&amp;usg=AOvVaw1pS3I25fkN7430zu3RFgWu">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Enhancing Care: Expansion of Alpers Disease Treatment
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.globenewswire.com › news-release › 2023/06/07 › Enhancing-Care-...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 7, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           BioMarin Pharmaceutical Inc. Genzyme Corporation (a subsidiary of Sanofi); Horizon Therapeutics plc; Ultragenyx Pharmaceutical Inc. Amicus ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEUQAg" href="/url?q=https://biopharmguy.com/links/company-by-name-acquired-defunct.php&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEUQAg&amp;usg=AOvVaw2SH7VVzZ9If4h_WHO5jAiC">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           2734 Terminally Acquired Biotech Companies - BioPharmGuy
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          biopharmguy.com › links › company-by-name-acquired-defunct
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Acquired by The Medicines Company, Feb 2015. Add'l Locations Annovis, Acquired by Transgenomic, May 2001. Add'l Locations AnorMED, Acquired by Genzyme, Oct 2006.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEgQAg" href="/url?q=https://www.linkedin.com/pulse/alpers-disease-treatment-market-grow-steady-cagr-457-during-eurwf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEgQAg&amp;usg=AOvVaw3t9i6YplW36mCT7E6g351-">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Alpers Disease Treatment Market To Grow At A Steady CAGR Of ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.linkedin.com › pulse › alpers-disease-treatment-market-grow-steady-...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 10, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           BioMarin Pharmaceutical Inc. Genzyme (a subsidiary of Sanofi). Horizon · Ultragenyx Pharmaceutical Inc. Amicus Therapeutics Inc. CRISPR ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECF4QAg" href="/url?q=https://www.linkedin.com/in/marilyn-vermilyea-22363a8&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECF4QAg&amp;usg=AOvVaw26kffF9UJX-HECxMA4R7r7">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Marilyn Vermilyea - Marlborough, Massachusetts, United States
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.linkedin.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc. · Location: Marlborough · 129 connections on LinkedIn. View Marilyn ... Focal, Inc. Documentation (an aquired Genzyme subsidiary). Lucent ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEcQAg" href="/url?q=https://media.nature.com/original/magazine-assets/d41573-023-00190-x/26372702&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEcQAg&amp;usg=AOvVaw3lfHmEEjrAbYJw6sZZD2E1">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [XLS] Sheet1 - Nature
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          media.nature.com › original › magazine-assets
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Genzyme Corp, Sanofi-Aventis SA, Multiple sclerosis (MS), 2011, https://www ... Inc-Announces-Acquisition-of-Viridian-Therapeutics-Inc.html, Acquisition. 87 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEQQAg" href="/url?q=https://dukespace.lib.duke.edu/bitstreams/d1968ac4-835f-4490-b92c-e0ee2e0b8af8/download&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEQQAg&amp;usg=AOvVaw2wwWDqeybhpcr4MhJPgNSA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Essays on Corporate Investment in Scientific Research - DukeSpace
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          dukespace.lib.duke.edu › bitstreams › download
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           company, because it has been spun-off by GENZYME CORP. A major contribution ... Compustat includes only the most recent name of the focal corporation.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEMQAg" href="/url?q=https://www.sweathelp.org/pdf/2020%2520-%2520Rice,%2520Pieretti%2520etc%2520-%2520Characterization%2520of%2520Disease%2520Awareness%2520and%2520Coping%2520Strategies%2520in%2520Primary%2520Focal%2520Hh%2520qualitative%2520focus%2520group%2520results%2520in%2520children.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEMQAg&amp;usg=AOvVaw2-fLpfKQbz4NBmFUtxEXqz">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Characterization of Disease Awareness and Coping Strategies in ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sweathelp.org › pdf › 2020 - Rice, Pieretti etc - Characterization ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Focal Hyperhidrosis: Qualitative Focus Group Results in Children, Adolescents, and Young ... Inc., a wholly‑owned subsidiary of Eli Lilly and Company, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEIQAg" href="/url?q=https://assets.aeaweb.org/asset-server/files/13979.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEIQAg&amp;usg=AOvVaw3OLYOQqx_8yvllFVqKXrWe">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Online Appendix for “Knowledge spillovers and corporate ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          assets.aeaweb.org › asset-server › files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           alone company in our data as it was not majority-owned by GENZYME CORP after it spun-off. 22 For example, Vysis Inc first enters our sample as a subsidiary ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEEQAg" href="/url?q=https://www.salary.com/job/5100-genzyme-corporation/program-demand-manager/j202304110947247511689&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEEQAg&amp;usg=AOvVaw3-mDeKB5Dkt-pu-0vbJMJ6">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Program Demand Manager Job Opening in Ridgefield, NJ at (5100 ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.salary.com › job › 5100-genzyme-corporation › program-demand-m...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Job Posting for Program Demand Manager at (5100) Genzyme Corporation ... focal point for markets supplied from Ridgefield ... Inc. and its U.S. ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEAQAg" href="/url?q=https://www.hrsa.gov/sites/default/files/hrsa/opa/orphan-drug-list-april-june-2022.xlsx&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECEAQAg&amp;usg=AOvVaw2xYA39Vx-UgvdMX-bqpl-k">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [XLS] Orphan Drug List - HRSA
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.hrsa.gov › files › hrsa › opa › orphan-drug-list-april-june-2022
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           GB002, Inc., a wholly-owned subsidiary of Gossamer Bio, Inc. 139, 138, (S)-3 ... For the enzymatic debridement of severe burns. Genzyme Corporation. 819 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECD8QAg" href="/url?q=https://publications.gc.ca/collections/collection_2021/isde-ised/Fr5-172-2000-eng.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECD8QAg&amp;usg=AOvVaw09TRYKTKzy_5Z3IX8Y21ka">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] biotechnology partnering opportunities - with - massachusetts life ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          publications.gc.ca › collection_2021 › isde-ised › Fr5-172-2000-eng
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           FOCAL, INC. 4 Maguire Road. Lexington, MA 02173. Tel: (781) 280-7800 ... GTC is a subsidiary of Genzyme and specializs in transgenic technology initiated at.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECD0QAg" href="/url?q=https://journals.lww.com/nuclearmed/fulltext/2024/06000/glial_activity_load_on_pet_reveals_persistent.1.aspx&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECD0QAg&amp;usg=AOvVaw2UNOLZnKehIda6HR_mtHyo">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Glial Activity Load on PET Reveals Persistent “Smoldering”
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          journals.lww.com › nuclearmed › fulltext › glial_activity_load_on_pet_rev...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           “Smoldering” inflammation is a recently popularized term used to describe widespread innate immune activation that is present beyond focal inflammatory lesions ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECD4QAg" href="/url?q=https://ir.travere.com/node/8821/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECD4QAg&amp;usg=AOvVaw1RQS9scwbK5mL2_A80vb4w">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing ID 0001571049-15-003959 - Travere Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.travere.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           On January 12, 2015, the Company announced the signing of a definitive agreement under which it acquired the exclusive right to purchase from Asklepion, all ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDwQAg" href="/url?q=https://ir.biohaven.com/static-files/003e3e19-c990-43d0-bfcd-d2b7ce91ea51&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDwQAg&amp;usg=AOvVaw3gPWIBp9suY_WKAyat6ZT0">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form DEF 14A for Biohaven LTD filed 03/18/2024
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.biohaven.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 18, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Ophthalmology at Sanofi Genzyme. ... As described further below, the Company and our wholly owned subsidiary, Biohaven Pharmaceuticals, Inc., have ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDkQAg" href="/url?q=https://www.cigna.com/static/www-cigna-com/docs/medicare/plans-services/2024/step-therapy-part-b-2024-july.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDkQAg&amp;usg=AOvVaw1yIQ0i3BRICC8rXzdQkd2_">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Questions about Step Therapy? - Cigna Healthcare
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cigna.com › docs › plans-services › step-therapy-part-b-2024-july
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol. 2004;151(6):1115-1122. 25. Porta M, Maggioni G. Botulinum toxin ( ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDoQAg" href="/url?q=https://sirnaomics.com/en/news-room/press-release/20120228/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDoQAg&amp;usg=AOvVaw1CdY6Ovmuw-IPos4dQgjyd">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Press Release | Sirnaomics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          sirnaomics.com › news-room › press-release
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 28, 2012
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Patrick Lu, President and CEO of Sirnaomics, Inc., will give a presentation entitled Developing siRNA Therapeutics for Clinical Studies in China ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDsQAg" href="/url?q=http://ir.scpharma.com/node/6641/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDsQAg&amp;usg=AOvVaw2m5ADnWwz92iVM5oFeSkVx">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | scPharmaceuticals, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.scpharma.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDgQAg" href="/url?q=https://www.healthadvantage-hmo.com/docs/librariesprovider6/default-document-library/ha-provider-manual.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDgQAg&amp;usg=AOvVaw0XInkZ3jHtyPBmcFmeKIL_">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Provider Manual | Health Advantage
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.healthadvantage-hmo.com › docs › default-document-library
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The focal point of case management in all of its roles ... The Employee Benefits Division (EBD) and Health Advantage, a subsidiary company of Arkansas Blue.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDcQAg" href="/url?q=https://investors.praxismedicines.com/static-files/97435d2f-53b4-414e-9aaf-66cf50a53278&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDcQAg&amp;usg=AOvVaw0byJezooHdAZEhj99BJWK1">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form 10-K for Praxis Precision Medicines INC filed 03/05/2024
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.praxismedicines.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 5, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           increasing responsibility at NPS Pharmaceuticals, Inc., Shire Human Genetic Therapies Inc. and Sanofi Genzyme Corporation. Mr. Souza served.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDYQAg" href="/url?q=https://www.macomptroller.org/wp-content/uploads/acfr_fy-2008.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDYQAg&amp;usg=AOvVaw35NCMiZyosXYccPXEpV3jF">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Commonwealth of Massachusetts Comprehensive Annual Financial ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.macomptroller.org › wp-content › uploads › acfr_fy-2008
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Fund financial statements focus on individual parts of the. Commonwealth ... profit subsidiary, the Worcester Foundation for Biomedical Research, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDUQAg" href="/url?q=https://projects.propublica.org/docdollars/company&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDUQAg&amp;usg=AOvVaw0wqjDyw4FIhdDLlBhPHkbm">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Companies Making Payments in 2018 | Dollars for Docs - ProPublica
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          projects.propublica.org › docdollars › company
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           FOCAL THERAPEUTICS, INC. 737, $19.6M. TAKEDA PHARMACEUTICALS U.S.A., INC. 211,384, $19.4M. ALCON RESEARCH LTD, 1,648, $17.4M.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDQQAg" href="/url?q=https://ir.aerovatetx.com/static-files/299c62b1-192e-4502-b9aa-0253d75b353c&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDQQAg&amp;usg=AOvVaw1UQTbUihloSPklcc07Ivik">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] 0001104659-21-084790.rtf - Aerovate Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.aerovatetx.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Genzyme, where he headed all launch planning and the commercialization of ... focal point for combination product issues for agency reviewers and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECC8QAg" href="/url?q=https://ir.exelixis.com/static-files/21cddf02-e799-43f7-ba64-227bb1dddfe2&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECC8QAg&amp;usg=AOvVaw1whCWI2Zih2uT02BkFEnM6">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form 10-K for Exelixis INC filed 02/06/2024
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.exelixis.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 27, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Performance Review: Focal reviews will take place annually. ... “Company” means Exelixis, Inc., its wholly owned subsidiaries, any successor to ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDAQAg" href="/url?q=https://www.cambridgema.gov/~/media/Files/budgetdepartment/citybondsale/Cambridge%2520PRELIM_2%252013%252013_1.ashx&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDAQAg&amp;usg=AOvVaw3AktiO7L59NVoR76gSzTyp">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] UBS Financial Services Inc. - the City of Cambridge
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cambridgema.gov › Files › budgetdepartment › citybondsale
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 15, 2013
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           In the opinion of Edwards Wildman Palmer LLP, Bond Counsel, based upon an analysis of existing law and assuming, among other matters, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDIQAg" href="/url?q=https://investor.bluebirdbio.com/static-files/600b5870-ec4b-4bc6-aaa5-cf967d10a115&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDIQAg&amp;usg=AOvVaw0rHdeCNQ796V3iXgzCk46R">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] bluebird bio, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.bluebirdbio.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Companies such as GlaxoSmithKline plc, Sanofi/Genzyme Corporation and. BioMarin Pharmaceutical Inc. are currently advancing programs in gene therapy, and in ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDEQAg" href="/url?q=https://static1.squarespace.com/static/593d9b08be65945a2e878544/t/5e664fee1761be3ae3c78144/1583763440485/Data%2BAppendix%2BAER%2B2020%2BMarch%2B9.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDEQAg&amp;usg=AOvVaw10OinLnRdfYlMdwbMy_v_H">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 1 ONLINE DATA APPENDIX FOR “KNOWLEDGE SPILLOVERS ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          static1.squarespace.com › static › Data+Appendix+AER+2020+March+9
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           based on prospectus submitted by the focal company ... 121742) and GENZYME BIOSURGERY (GVKEY 143176) are all accounted under their parent company GENZYME CORP.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDMQAg" href="/url?q=https://investors.artivion.com/static-files/4a3bff84-22f2-4107-945f-989c824c17b9&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECDMQAg&amp;usg=AOvVaw3rXkL2bQXv-BN3pxN9VaOl">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [RTF] 0000914062-01-500169.rtf - Investor Overview
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.artivion.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Braun GmbH, Focal, Inc., Fusion Medical Technologies. Inc. and Cohesion ... Compass Retail Inc, a wholly-owned subsidiary of Equitable Real Estate. From.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECC4QAg" href="/url?q=https://www.vbivaccines.com/evlp-platform/louis-pasteur-attenuated-vaccine/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECC4QAg&amp;usg=AOvVaw08bV6Mc6fnAC5BJN6d5Hla">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Louis Pasteur and the Development of the Attenuated Vaccine
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.vbivaccines.com › evlp-platform › louis-pasteur-attenuated-vaccine
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 23, 2016
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Genzyme Corporation. Mr. McNulty holds B.S. and M.Eng. degrees from the Massachusetts Institute of Technology, as well as an M.B.A. from ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCwQAg" href="/url?q=https://www.controlledreleasesociety.org/sites/default/files/docs/2018/Vol34No5FULL.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCwQAg&amp;usg=AOvVaw23vbt5u_Jji_8Me68l7-we">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Newsletter - Controlled Release Society
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.controlledreleasesociety.org › sites › default › files › docs
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... (acquired by Covidien), chairman of MarketRx. (acquired by Cognizant), and technology founder of both Focal Inc. (acquired by Genzyme) and Access. Closure Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECC0QAg" href="/url?q=https://www.jaad.org/article/S0190-9622(20)32221-0/pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECC0QAg&amp;usg=AOvVaw11MD0rVD9LrgxZVRei8ZjT">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Drugs associated with development of pityriasis rubra pilaris
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.jaad.org › article › pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Medicine, Inc, a wholly owned subsidiary of. Roche Holdings, Inc and Roche ... Regeneron, Roche, Sanofi Genzyme, Takeda,. UCB, Valeant, and Xenon. Dr ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCsQAg" href="/url?q=https://d18rn0p25nwr6d.cloudfront.net/CIK-0000719739/6f16c4d0-43a8-4271-b5b7-a0f1be207ddd.xls&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCsQAg&amp;usg=AOvVaw3ulAI6hJibzLIKTmiL_D6T">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [XLS] Table_Of_Contents - cloudfront.net
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          d18rn0p25nwr6d.cloudfront.net › CIK-0000719739
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           • Focal, Inc., a public company developer of surgical sealants. 32, (acquired by Genzyme/Sanofi) (1994 to 1999). 33. 34, Other Prior, • President and Chief ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCoQAg" href="/url?q=https://cdn.cdo.mit.edu/wp-content/uploads/sites/67/2019/07/Cover-Letter-Sample-Packet-Revised-2017-2018.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCoQAg&amp;usg=AOvVaw1jLWHWf9ZtVkbt5k6WzdZX">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] CREATING A POWERFUL COVER LETTER
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          cdn.cdo.mit.edu › Cover-Letter-Sample-Packet-Revised-2017-2018
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Included here are examples of job descriptions and successful cover letters and resumes. (meaning the students were asked to interview with the company) as well ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCcQAg" href="/url?q=https://www.biospectrumindia.com/news/18/238/bio-news.html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCcQAg&amp;usg=AOvVaw3cz9LQbItqH00sA51pFZrC">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Bio News - BioSpectrum India
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.biospectrumindia.com › news › bio-news
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 5, 2008
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Henri A. Termeer, chairman and chief executive officer of Genzyme Corporation ... wholly owned subsidiary, Advinus Therapeutics Inc. The US ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCgQAg" href="/url?q=https://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/2007-conference-program.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCgQAg&amp;usg=AOvVaw0-debq0E0hZgjAExw5BRO-">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Conference Program - The Personalized Medicine Coalition
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.personalizedmedicinecoalition.org › PMC-Corporate › file › 20...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 29, 2007
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Inc., Durham, NC. Presentation by: Mara G. Aspinall. President, Genzyme Genetics, Genzyme Corporation, Westborough, MA. Introduction by: Edward ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCkQAg" href="/url?q=https://www.researchgate.net/publication/265860127_Eliglustat_First_Global_Approval&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCkQAg&amp;usg=AOvVaw3w54W7_UZE8FlSggclw7Ek">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Eliglustat: First Global Approval - ResearchGate
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.researchgate.net › publication › 265860127_Eliglustat_First_Global_...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... For example, eliglustat (1, Cerdelga ® , Genzyme Corp. United States) has been used for treating Gaucher disease by inhibiting glucosylceramide synthase [4][ ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECGEQAg" href="/url?q=https://investors.cerevel.com/node/7626/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECGEQAg&amp;usg=AOvVaw0Dwb8MKJ-JuEWp4Fe-KV00">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Pfizer license agreement - SEC Filing | Cerevel Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.cerevel.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... focal onset seizures in epilepsy, or focal epilepsy, and a ... wholly owned subsidiary of ARYA and ARYA was renamed Cerevel Therapeutics Holdings, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCQQAg" href="/url?q=https://rarediseases.org/clinical-trial/page/3/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCQQAg&amp;usg=AOvVaw3WrHRl94fQ0k9bHhCux8XU">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Clinical Trials - Page 3 of 4 - National Organization for Rare Disorders
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          rarediseases.org › clinical-trial › page
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Primary Focal Segmental Glomerulosclerosis (FSGS). Travere Therapeutics, Inc. is sponsoring a study to determine the long-term nephroprotective potential of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCYQAg" href="/url?q=https://investors.medicinova.com/node/10446/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCYQAg&amp;usg=AOvVaw04G96z6GhsmoC0PSWruijO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - MediciNova, Inc. - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.medicinova.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           In October 2012 we met with the FDA to review future development of this product candidate. The FDA identified the risk/benefit profile of MN-221 as a focal ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCMQAg" href="/url?q=https://www.neurology.org/doi/10.1212/WNL.0000000000207402&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCMQAg&amp;usg=AOvVaw1Yuqqq7r53W1e2Ht3XO_1Z">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Efficacy and Safety of Elamipretide in Individuals With Primary ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.neurology.org › doi › WNL.0000000000207402
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... focal point to be addressed in future therapeutic trials. Refining the ... Inc., (7) Moderna Therapeutics, (8) Genzyme Corporation. Research Support ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCIQAg" href="/url?q=https://ir.mallinckrodt.com/static-files/b243f547-5502-46f6-a745-81bd18cd8ec6&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCIQAg&amp;usg=AOvVaw3mw1TlkPUbqEsJj0RQQ8BO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Questcor Pharmaceuticals, Inc. - Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.mallinckrodt.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... wholly owned subsidiary of Parent, and RiboGene, Inc ... any liability of the Company under the asset purchase agreement between the Company and Genzyme.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCEQAg" href="/url?q=https://che.utexas.edu/alumni/academy-of-distinguished-chemical-engineers/inaugural-class&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCEQAg&amp;usg=AOvVaw1Ha_LzeUArUHAj5CV0wa6x">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Inaugural Class - McKetta Department of Chemical Engineering
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          che.utexas.edu › alumni › academy-of-distinguished-chemical-engineers
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... subsidiary of Texaco, Inc. In 1972 ... (acquired by Covidien), the technology founder of Focal, Inc. (acquired by Genzyme) and of Access Closure, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECB0QAg" href="/url?q=https://www.gibsondunn.com/2015-year-end-fda-and-health-care-compliance-and-enforcement-update-drugs-and-devices/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECB0QAg&amp;usg=AOvVaw1B6YpJHoZr4sjkp8PtvTsq">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           2015 Year-End FDA and Health Care Compliance and Enforcement ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.gibsondunn.com › 2015-year-end-fda-and-health-care-compliance-a...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 19, 2016
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... company's president.[38]. In September 2015, Genzyme Corporation, a wholly owned biotechnology subsidiary of Sanofi, agreed to pay $32.5 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECB8QAg" href="/url?q=https://investors.biogen.com/static-files/76edcab0-0179-40ab-8232-aee2484c2d26&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECB8QAg&amp;usg=AOvVaw0tcbRkfeBN17RE-c8cCZJ4">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Form 10-K - Biogen | Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.biogen.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           BIOGEN INC. (Exact name of registrant as specified in its charter). Delaware ... subsidiary of Alkermes plc (Alkermes), submitted a New Drug Application ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECB4QAg" href="/url?q=https://www.cms.gov/files/document/open-payments-fy-2021-annual-report-congress.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECB4QAg&amp;usg=AOvVaw2p_EXpMzNjxTgqYrwyUPTE">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Open Payments Annual Report to Congress Fiscal Year 2021 - CMS
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cms.gov › files › document › open-payments-fy-2021-annual-r...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Genzyme Corporation. $23,435,246.01. $14,362,324.79. $0.00. $0.00. 40,336 ... Jacobus Pharmaceutical Company, Inc. $0.00. $16,000.00. $0.00. $0.00. 0. 1. 0. 0. 0.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBwQAg" href="/url?q=https://www.annualreports.com/HostedData/AnnualReportArchive/s/NYSE_SNY_2012.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBwQAg&amp;usg=AOvVaw3c6Uq9LEMDmgQDbnbRnqiU">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Annual Report on Form 20-F 2012 - AnnualReports.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.annualreports.com › AnnualReportArchive › NYSE_SNY_2012
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 25, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Inc.; BiTE a trademark of Micromet Inc., Copaxone a trademark of Teva Pharmaceuticals Industries; Cortizone-10 a trademark of Johnson ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCAQAg" href="/url?q=https://www.cirm.ca.gov/wp-content/uploads/archive/files/press_release/Top_50_Global_Stem_Cell_Influencers.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECCAQAg&amp;usg=AOvVaw1ZtXNdgqhuwdVe-f7Ax1-2">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Top 50 most influential people on Stem Cells today
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cirm.ca.gov › files › Top_50_Global_Stem_Cell_Influencers
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Manager at Genzyme, a Sanofi company, ... Arnold Caplan, has been Chief Scientific. Officer of OrthoCyte Corporation, a subsidiary of BioTime, Inc., since June ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBsQAg" href="/url?q=https://www.uscis.gov/sites/default/files/document/data/Approved_H1B_2017_Employers_3.2.18.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBsQAg&amp;usg=AOvVaw17Cj2N0AzZ_8NKerFRIWpU">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Approved H-1B Petitions (Number, Salary, and Degree/Diploma) by ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.uscis.gov › sites › default › files › document › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... INC. 4,931. 78,443 Bachelor's. 3,143. Master's. 1,730. High School. 29. Professional ... SUBSIDIARY O. 16. 64,650 Master's. H. Bachelor's. D. 2702 PHILLIPS 66 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBkQAg" href="/url?q=https://investor.bankofamerica.com/regulatory-and-other-filings/subsidiary-and-country-disclosures/merrill-lynch-all-sec-filings/content/0000065100-02-000005/0000065100-02-000005.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBkQAg&amp;usg=AOvVaw3qKGBmpnCzS4vt0wCbwZXt">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] united states - Bank of America Investor Relations
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.bankofamerica.com › merrill-lynch-all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Merrill Lynch &amp; Co., Inc. (ML&amp;Co.) is the parent holding company of a number of operating subsidiaries some of which are or may be institutional.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBoQAg" href="/url?q=https://erasmus.gr/microsites/1110/sponsors-exhibitors&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBoQAg&amp;usg=AOvVaw30ICrYxu0857tgRYlaR4b5">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Sponsors &amp; Exhibitors - 10th International Symposium on Focal ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          erasmus.gr › microsites › sponsors-exhibitors
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Gold Sponsor Company Profile www.btgplc.com About BTG At BTG we are focused on bringing to market.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBgQAg" href="/url?q=https://investors.tenayatherapeutics.com/node/6311/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBgQAg&amp;usg=AOvVaw3-fikTIzKAzs0yOGCDAf3l">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Tenaya Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.tenayatherapeutics.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Genzyme Corporation. Since inception, we have raised approximately $248 million in equity financing from leading venture, strategic and public investors ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBcQAg" href="/url?q=https://investors.atyrpharma.com/node/6736/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBcQAg&amp;usg=AOvVaw1dnenJawKAYq4ISt5s0tgl">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | aTyr Pharma
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.atyrpharma.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           This is the initial public offering of shares of common stock of aTyr Pharma, Inc. We are offering shares to be sold in this offering. Prior to this offering, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBYQAg" href="/url?q=https://investor.arbutusbio.com/node/14821/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBYQAg&amp;usg=AOvVaw0erOLdlM01drLd1kwQhNqA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Arbutus Biopharma Corporation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.arbutusbio.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Prior to that, Mr. Hastings was with Genzyme Corporation as its Vice President and Corporate Controller, and with Sepracor, Inc. where he was Director of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBIQAg" href="/url?q=https://www.zionmarketresearch.com/news/global-alpers-disease-treatment-market&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBIQAg&amp;usg=AOvVaw3t6zjzNV92WylAvG6OjvlP">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Alpers Disease Treatment Market- Size, Statistics, Segments, Forecast
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.zionmarketresearch.com › news › global-alpers-disease-treatment-ma...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 7, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Genzyme Corporation (a subsidiary of Sanofi); Horizon Therapeutics plc; Ultragenyx Pharmaceutical Inc. Amicus Therapeutics Inc. CRISPR ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBQQAg" href="/url?q=https://esd.ny.gov/sites/default/files/news-articles/32918-ESD-Posting-Materials.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBQQAg&amp;usg=AOvVaw2UMI5AYsWDCP_8QdxZJRoI">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] NYS Urban Development Corporation Meeting
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          esd.ny.gov › sites › files › news-articles › 32918-ESD-Posting-Materials
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 29, 2018
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           (Senior Vice President) and Genzyme (Director of Corporate Development). Emerging research over the last couple of decades has shown that ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBEQAg" href="/url?q=https://www.dealpointdata.com/rj%3Fvb%3DAction.downloadPDF%26app%3Dcorp%26id%3D000193597924000026_bhvn-20240314htm&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBEQAg&amp;usg=AOvVaw1mCur-Ts89pmhWAOx8pW9z">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Biohaven Ltd. - Deal Point Data
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.dealpointdata.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 18, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Next steps: We look forward to advancing BHV-7000 in an array of clinical studies for focal ... subsidiary, Biohaven Pharmaceuticals, Inc., have ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBUQAg" href="/url?q=https://www.adcreview.com/drugmap/bivatuzumab-mertansine/&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBUQAg&amp;usg=AOvVaw2esKYyavWE90_DTc_A7fmr">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Bivatuzumab mertansine | Anti-CD44v6-DM1 | BIWI-1 - ADC Review
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.adcreview.com › drugmap › bivatuzumab-mertansine
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The maximum tolerated dose (MTD) was 300 mg/m2 attributable to skin toxicity. The principal toxic effects were maculopapular rashes, focal blister formation, ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBMQAg" href="/url?q=https://www.fdanews.com/ext/resources/files/archives/1/10/100410_IOM_Report.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBMQAg&amp;usg=AOvVaw2YFkgrHq3ZdC715Ro8IU-7">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Rare Diseases and Orphan Products: Accelerating Research and ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.fdanews.com › ext › files › archives › 100410_IOM_Report
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Approval Letter to Genzyme Corporation for BLA 125141/0. [Alglucosidease alfa / Myozyme]. April 28. PREPUBLICATION COPY: UNCORRECTED PROOFS. Page 234. R-4.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBAQAg" href="/url?q=https://www.nber.org/system/files/working_papers/w23187/w23187.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECBAQAg&amp;usg=AOvVaw2XomvX15s6_o6RU6Z9PdJv">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Back to Basics: Why do Firms Invest in Research?
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.nber.org › system › files › working_papers
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 6, 2017
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           companies in the NBER database, we merge BOEING CAPITAL CORP under BOEING CO as it is a wholly owned subsidiary of the company. ... GENZYME CORP- ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECA8QAg" href="/url?q=https://journals.lww.com/cjasn/fulltext/2022/10000/perspectives_on_drug_development_in_autosomal.19.aspx&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECA8QAg&amp;usg=AOvVaw3q_dAy6DCCrpF8uQ8tqvYD">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Perspectives on Drug Development in Autosomal Recessive Poly...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          journals.lww.com › cjasn › fulltext › perspectives_on_drug_development_i...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Genzyme; research funding from Kadmon, Palladiobio, Reata, and Sanofi ... Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECA4QAg" href="/url?q=https://www.medchemexpress.com/Rapamycin.html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECA4QAg&amp;usg=AOvVaw1-_KdFANj7mmOdytCgT-CM">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Rapamycin (Sirolimus) | mTOR Inhibitor - MedchemExpress.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.medchemexpress.com › PI3K/Akt/mTOR › mTOR › Rapamycin
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div class="v9i61e">
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Rating
           </span>
           <span class="r0bn4c rQMQod tP9Zud">
            <span>
            </span>
            <span aria-hidden="true" class="oqSTJd">
             5.0
            </span>
            <span>
            </span>
            <div aria-label="Rated 5.0 out of 5" class="Hk2yDb KsR1A" role="img">
             <span style="width:65px">
             </span>
            </div>
            <span>
            </span>
            <span>
            </span>
            <span>
            </span>
           </span>
          </div>
         </div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Mayo Clinic|Wyeth is now a wholly owned subsidiary of Pfizer|Genzyme, a Sanofi Company|Roche Pharma AG. Kidney Diseases. April 2001, Phase 4. NCT03910452 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECA0QAg" href="/url?q=https://www.auriniapharma.com/investors-and-media/sec-filings/all-sec-filings/content/0001157523-20-000260/0001157523-20-000260.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECA0QAg&amp;usg=AOvVaw0wG_PlOb65h2nj8p5cRttv">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] FORM 6-K - Aurinia Pharmaceuticals
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.auriniapharma.com › sec-filings › all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 25, 2020
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           VICTORIA, British Columbia--(BUSINESS WIRE)--February 25, 2020--Aurinia Pharmaceuticals Inc. ... nephritis, focal segmental glomerulosclerosis and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAoQAg" href="/url?q=https://www.hrsa.gov/sites/default/files/hrsa/opa/orphan-drug-list-october-1-december-31-2022.xlsx&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAoQAg&amp;usg=AOvVaw3r0m68X-z5vSftaP3c0cSH">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [XLS] Orphan Drug List Governing January 1 to March 31, 2019 - HRSA
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.hrsa.gov › opa › orphan-drug-list-october-1-december-31-2022
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           GB002, Inc., a wholly-owned subsidiary of Gossamer Bio, Inc. 152, 151, (S)-3 ... Treatment of chronic lymphocytic leukemia. Genzyme Corporation. 723, 722 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAsQAg" href="/url?q=https://scilexholding.gcs-web.com/node/8291/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAsQAg&amp;usg=AOvVaw1RVgK_YrZrD1Qew7DOnEtG">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Hosted Pages - Scilex Holding Company
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          scilexholding.gcs-web.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Additionally, Genzyme may terminate the Genzyme Supply Agreement if it ... focal point for communication between candidates, non-committee directors ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAkQAg" href="/url?q=https://elsevier.health/en-US/preview/dexamethasone&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAkQAg&amp;usg=AOvVaw0iw4_mPH_8zyJGicecNcd5">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Dexamethasone - Elsevier healthcare hub
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          elsevier.health › en-US › preview › dexamethasone
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Inc, a subsidiary of Wockhardt, Ltd.) null Dexamethasone 0.5mg/5ml Elixir ... Cambridge, MA: Genzyme Corporation; 2010 Dec.7714 - Schimmer B, Parker K ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAwQAg" href="/url?q=https://www.bayer.com/sites/default/files/2020-05/ar-2016.pdf&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAwQAg&amp;usg=AOvVaw1Wk9moDVijpqb0znMyEcng">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Annual Report - Bayer
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bayer.com › sites › default › files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... focal point was submitting proposals for creating sustainable health care ... Inc.,. United States, to jointly develop a combination therapy of the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAAQAg" href="/url?q=http://pauling.us/12thSymposiumSpeakers.html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAAQAg&amp;usg=AOvVaw1SzU5AbhFeCQDsLTzK52Xh">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Symposium Speakers - Linus Pauling Biotech Symposium
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          pauling.us › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Focal, Inc. (1993-2000), and Vice President, Biomaterials Research at Genzyme Corporation (2000-present). His career focus has been polymeric biomaterials ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAEQAg" href="/url?q=https://investors.bellerophon.com/node/7366/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAEQAg&amp;usg=AOvVaw3Tc0M5kwwaA5ozzRPc0gxU">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Investors | Bellerophon Therapeutics, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.bellerophon.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We currently have three wholly-owned subsidiaries: Bellerophon BCM LLC, a Delaware limited liability company; Bellerophon Pulse Technologies LLC, a Delaware ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAMQAg" href="/url?q=https://ir.biohaven.com/static-files/e8b390f1-a1db-410e-9ce4-3ce91eb38fb0&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAMQAg&amp;usg=AOvVaw3U6-bRLNe_kONMCSCYAHQ8">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] biohaven ltd.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.biohaven.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Focal Epilepsy and Bipolar Disorder in second half of 2023. Biohaven ... (the "Former Parent"), Pfizer Inc. (“Pfizer”) and a wholly owned subsidiary ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAcQAg" href="/url?q=https://www.aetna.com/cpb/medical/data/200_299/0247.html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAcQAg&amp;usg=AOvVaw1xnvi4ZjlwIKqrpOHiiXNn">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Autologous Chondrocyte Implantation - Medical Clinical ... - Aetna
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.aetna.com › cpb › medical › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... focal chondral defect with all of the following: ... Autologous chondrocyte implants (autologous chondrocyte transplant) (Carticel, Genzyme Inc ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAUQAg" href="/url?q=https://www.humanservices.state.pa.us/PROVIDER_REIMBURSEMENT&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAUQAg&amp;usg=AOvVaw3-fIUohOZXwZ0hSA3lKWO5">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Search Provider Page Human Services Facilities
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.humanservices.state.pa.us › PROVIDER_REIMBURSEMENT
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           FOCAL CORPORATION, FOCAL POINT EYEWEAR, FOCKLER CRAIG H, FOCUS BEHAVIORAL HEALTH INC, FOCUS HEALTH INC ... GENZYME GENETICS, GEOFFREY B MONSOUR MD, GEOFFREY B ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad xpd EtOod pkphOe">
     <div class="kCrYT">
      <span class="cAuxJf">
       <div class="BNeawe">
        <span class="BNeawe">
         <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQsAR6BAhkEAE" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=b6aWZozZGZ3KkPIP_-mcyAI&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQsAR6BAhkEAE">
          <span>
           <span class="FCUp0c rQMQod">
            Images
           </span>
          </span>
         </a>
        </span>
       </div>
      </span>
      <div class="BNeawe tAd8D AP7Wnd">
       <span class="BNeawe">
        <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ7Al6BAhkEAI" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=b6aWZozZGZ3KkPIP_-mcyAI&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ7Al6BAhkEAI">
         <span class="tAd8D AP7Wnd">
          <span class="rQMQod Xb5VRe">
           View all
          </span>
         </span>
        </a>
       </span>
      </div>
     </div>
     <div>
      <div>
       <div>
        <div class="Xdlr0d">
         <div class="idg8be">
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAQ" href="https://www.google.com/imgres?imgurl=https://upload.wikimedia.org/wikipedia/commons/9/93/Genzyme_building.jpg&amp;imgrefurl=https://en.wikipedia.org/wiki/Genzyme&amp;h=3008&amp;w=2000&amp;tbnid=Z6XGeD5lfmLg2M&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbnh=150&amp;tbnw=100&amp;usg=AI4_-kQLrDDuk7it7kvEcciX1N1ZUw_xEw&amp;vet=1&amp;docid=ntwS8Q055r9mqM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAQ">
           <div>
            <img alt="Genzyme - Wikipedia" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRuwahQ4d4wk1Lz9Y9Vo1f6CUvhNhbaXSJpoBwaFDzZzyEoXVfgTGPD_b2qAg&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAY" href="https://www.google.com/imgres?imgurl=https://upload.wikimedia.org/wikipedia/commons/thumb/f/f0/Genzyme_plant%252C_Allston%252C_Massachusetts.jpg/300px-Genzyme_plant%252C_Allston%252C_Massachusetts.jpg&amp;imgrefurl=https://en.wikipedia.org/wiki/Genzyme&amp;h=142&amp;w=300&amp;tbnid=pTlBRiENIhvmaM&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbnh=55&amp;tbnw=116&amp;usg=AI4_-kS_GALirZYbojwrl1M850cjNjNoAA&amp;vet=1&amp;docid=ntwS8Q055r9mqM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAY">
           <div>
            <img alt="Genzyme - Wikipedia" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQR1W0pL9yEwjdat6IE5E9MBAoQ3fjBc_9D0fi9wDTnmVAEugbfHb2hrxLY2w&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAg" href="https://www.google.com/imgres?imgurl=https://image.pitchbook.com/beyLBlsJMr4zZZEZaMqRWAFhi4l1603769676818_200x200&amp;imgrefurl=https://pitchbook.com/profiles/company/25274-35&amp;h=200&amp;w=200&amp;tbnid=RKNJQwHgaO9l7M&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbnh=104&amp;tbnw=104&amp;usg=AI4_-kSWW0T7UaHiEoC3SGFNw9pk-h4NZg&amp;vet=1&amp;docid=b0gOP6Q_K2jvIM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAg">
           <div>
            <img alt="Sanofi Genzyme Company Profile 2024: Valuation, Investors ..." class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSiNR3jwy8I_rvmyVoTrHldosYr_ejcLlvL-qS37to437xuCyMg6bmZwwEj3Ng&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAo" href="https://www.google.com/imgres?imgurl=https://www.sec.gov/Archives/edgar/data/732485/000104746909004080/g93332bei001.gif&amp;imgrefurl=https://www.sec.gov/Archives/edgar/data/732485/000104746909004080/a2192147zdef14a.htm&amp;h=880&amp;w=680&amp;tbnid=LvKIBTTb8vth1M&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbnh=146&amp;tbnw=113&amp;usg=AI4_-kQ2NVWb7d05-ZWywH5TRuEcpxBM9Q&amp;vet=1&amp;docid=-mV9j0UBxC0HxM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAo">
           <div>
            <img alt="g93332bei001.gif" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRLsnmjiEAXo7N8erhxQJ5tp2VwTWU6ltTjHUek44hQk3rN05WkWcsF4r7r8A&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAw" href="https://www.google.com/imgres?imgurl=https://www.sec.gov/Archives/edgar/data/732485/000110465906024858/g75571dii001.jpg&amp;imgrefurl=https://www.sec.gov/Archives/edgar/data/732485/000110465906024858/a06-7557_1def14a.htm&amp;h=324&amp;w=557&amp;tbnid=ukFVuEKFNVCZLM&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbnh=77&amp;tbnw=133&amp;usg=AI4_-kThRrCaFgu_k9PbHPJy4LcWvZ1Zkw&amp;vet=1&amp;docid=tDFeEIdWzO6gmM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEAw">
           <div>
            <img alt="g75571dii001.jpg" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQpJATibZXbMuu9coDAaQBTVfZXEabIIdGNUHTCqvJJxUaVjTaBTbs5R4MpIA&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEA4" href="https://www.google.com/imgres?imgurl=https://www.sec.gov/Archives/edgar/data/732485/000104746909004080/g93332bii001.gif&amp;imgrefurl=https://www.sec.gov/Archives/edgar/data/732485/000104746909004080/a2192147zdef14a.htm&amp;h=880&amp;w=680&amp;tbnid=LbawxNHoLapgMM&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbnh=146&amp;tbnw=113&amp;usg=AI4_-kTVhRDDd8W2vIKng6uCQU8nrZAhDA&amp;vet=1&amp;docid=-mV9j0UBxC0HxM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEA4">
           <div>
            <img alt="g93332bii001.gif" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRr-EygG3Wf0S73tuLdAoJXxXqH8P4nU3TE3Ks9pvV1R1qW2edRh6gseLlOVQ&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEBA" href="https://www.google.com/imgres?imgurl=https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1333542758%2520%25281%2529.jpg?VersionId%3DlB0jcF3uhqkdBoIR4cghvaGUhsE4OHB2&amp;imgrefurl=https://synapse.patsnap.com/organization/bbc5fe68369d38a0223445bb4a014033&amp;h=853&amp;w=1280&amp;tbnid=21VcM_Yz0kiiHM&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbnh=100&amp;tbnw=150&amp;usg=AI4_-kQV_P-I1a8pYXZ_hYzBCfd5i4PEvg&amp;vet=1&amp;docid=TDoVh0CAQhlaJM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEBA">
           <div>
            <img alt="Genzyme Corp. - Drug pipelines, Patents, Clinical trials - Synapse" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRmPl4P6-pi3_9AYRXTljA_lLdpoWfsbH_oPZC6vuULPkK_n-eZWv1qlex-tQ&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEBI" href="https://www.google.com/imgres?imgurl=https://cdn.kscope.io/8ebac070fa36c1e6afcd087c6ec259f8-pg22.jpg&amp;imgrefurl=https://ir.travere.com/node/8821/html&amp;h=505&amp;w=670&amp;tbnid=ERgSpNRh_0YpmM&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbnh=104&amp;tbnw=138&amp;usg=AI4_-kT4INs7VnLpR5XolVtDwMsSNfRz5A&amp;vet=1&amp;docid=dtKQPgFbu7ZdAM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEBI">
           <div>
            <img alt="SEC Filing ID 0001571049-15-003959 | Travere Therapeutics, Inc." class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSq6OY3RZHUUUyl99MGmq1VcTrDPytHg8-TVT5R7H9Qk-gSEDUGVHrJQfe9Z2E&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEBQ" href="https://www.google.com/imgres?imgurl=https://www.sec.gov/Archives/edgar/data/1452965/000119312521284328/g123908g54d82.jpg&amp;imgrefurl=https://www.sec.gov/Archives/edgar/data/1452965/000119312521284328/d123908ds1.htm&amp;h=264&amp;w=605&amp;tbnid=8fJE4q1cNCgtZM&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbnh=59&amp;tbnw=135&amp;usg=AI4_-kTqp8wTkIxhPXWwaRGGjsDmnv3qsg&amp;vet=1&amp;docid=qqrrwU9iCnIFeM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ9QF6BAhkEBQ">
           <div>
            <img alt="Registration Statement on Form S-1" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQtYErQCQo-EWjYcCkBXkWi0zCwgAmEUS480IsVUrC7aAsn-lkGuxbxcPmByg&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <div class="mHhylf">
           <div class="WZ5GJf">
            <a class="qN9Ked" data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ7Al6BAhkEBU" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=b6aWZozZGZ3KkPIP_-mcyAI&amp;q=Genzyme+subsidiary+Focal,+Inc.&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQ7Al6BAhkEBU">
             <button class="DXk5Me Qi9Fd" tabindex="-1">
              <span class="hWHuJ">
               <span class="Dk7jOe z1asCe lYxQe">
                <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
                 <path d="M12 4l-1.41 1.41L16.17 11H4v2h12.17l-5.58 5.59L12 20l8-8z">
                 </path>
                </svg>
               </span>
              </span>
             </button>
             <div class="BNeawe ji5jpf s3v9rd AP7Wnd">
              View all
             </div>
            </a>
           </div>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAgQAg" href="/url?q=https://investors.vrtx.com/static-files/281eaa29-0e92-4113-8286-7c85d9bbb748&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAgQAg&amp;usg=AOvVaw0fwofHYxgjC8IBaw7XGTnN">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [DOC] Download DOC - Investor Relations | Vertex Pharmaceuticals
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.vrtx.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Incorporated, a Massachusetts corporation, and its subsidiaries. “VERTEX ... Genzyme Business Unit focused on Inflammation/Immunology, Rare Disease ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAIQAg" href="/url?q=https://ir.microbotmedical.com/node/7866/html&amp;sa=U&amp;ved=2ahUKEwjMzObog6yHAxUdJUQIHf80BykQFnoECAIQAg&amp;usg=AOvVaw1hINIWnpm1MG_MhKZCHRxB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Microbot Medical Inc
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.microbotmedical.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           and Genzyme, an Elan Corporation. These companies already ... Levin was Chief Executive Officer and a director of Focal, Inc., a biomedical company.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <footer>
    <div>
     <div class="Gx5Zad xpd EtOod pkphOe BmP5tf">
      <div class="nMymef Va3FIb lVm3ye">
       <a aria-label="Next page" class="nBDE1b G5eFlf" href="/search?q=Genzyme+subsidiary+Focal,+Inc.&amp;num=100&amp;lr=lang_en&amp;sca_esv=838ca97d1d112653&amp;sca_upv=1&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=b6aWZozZGZ3KkPIP_-mcyAI&amp;start=100&amp;sa=N">
        Next &gt;
       </a>
      </div>
     </div>
    </div>
    <div id="EOlPnc">
     <div class="Srfpq">
      <div>
       <span class="EYqSq unknown_loc">
       </span>
       <span class="dfB0uf">
        California
       </span>
      </div>
      <span>
       From your IP address
      </span>
      <span>
       -
      </span>
      <a aria-label="Learn more about this location" class="IffyKc" href="/url?q=https://support.google.com/websearch%3Fp%3Dws_settings_location%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQty4I-AM&amp;usg=AOvVaw2qw3AvCJNfs-s5SM7c1v6O" tabindex="0">
       Learn more
      </a>
     </div>
     <div>
      <a href="/url?q=https://accounts.google.com/ServiceLogin%3Fcontinue%3Dhttps://www.google.com/search%253Fhl%253Den%2526source%253Dhp%2526q%253DGenzyme%252Bsubsidiary%252BFocal,%252BInc.%2526btnG%253DGoogle%252BSearch%2526iflsig%253DAL9hbdgAAAAAZpa0f0F8S4afo_Lcs2_eeIcoXheM8Jht%2526gbv%253D1%2526lr%253Dlang_en%2526gl%253Dus%2526num%253D100%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQxs8CCPkD&amp;usg=AOvVaw0T78zH5cSxrr7BBMe9m1Ao">
       Sign in
      </a>
     </div>
     <div>
      <a class="xeDNfc" href="https://www.google.com/preferences?hl=en&amp;fg=1&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQ5fUCCPoD">
       Settings
      </a>
      <a class="xeDNfc" href="https://policies.google.com/privacy?hl=en&amp;fg=1">
       Privacy
      </a>
      <a class="xeDNfc" href="https://policies.google.com/terms?hl=en&amp;fg=1">
       Terms
      </a>
      <a class="xeDNfc" href="/setprefs?hl=en&amp;prev=https://www.google.com/search?hl%3Den%26source%3Dhp%26q%3DGenzyme%2Bsubsidiary%2BFocal,%2BInc.%26btnG%3DGoogle%2BSearch%26iflsig%3DAL9hbdgAAAAAZpa0f0F8S4afo_Lcs2_eeIcoXheM8Jht%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26pccc%3D1&amp;sig=0_XiSe1Aqy8q57D2k7XI_dPwhkBDw%3D&amp;cs=2&amp;sa=X&amp;ved=0ahUKEwjMzObog6yHAxUdJUQIHf80BykQjcAJCPsD">
       Dark theme: Off
      </a>
     </div>
    </div>
   </footer>
  </div>
  <!-- cctlcm 5 cctlcm -->
  <textarea class="csi" name="csi" style="display:none"></textarea>
 </body>
</html>
